Compare T-Rex 2X Long MSTR Daily Target ETF (MSTU) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Long MSTR Daily Target ETF vs Twist Bioscience Corp — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $30.65, while Twist Bioscience Corp trades at $124.3 (market cap $8.26B). The key difference: Twist Bioscience Corp is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| MSTU | TWST | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $573.00 | $153.10 |
52-Week Low | $14.60 | $24.16 |
Market Cap | — | $8.26B |
Enterprise Value | — | $8.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTU trades at $33.31, down 8.64% today, with technical indicators showing a bullish trend supported by moving averages. The ETF recently underwent a 10:1 reverse stock split and declared a $0.29 dividend payable in August 2026. Recent news highlights significant trading activity as investors seek leveraged exposure to MicroStrategy amid Bitcoin volatility, though the fund has experienced substantial value erosion over the past year.
The outlook remains volatile given MSTU's leveraged structure, which compounds daily moves. While technical momentum appears positive, fundamental risks include the amplified exposure to MicroStrategy's performance and crypto market swings. Investors should weigh the potential for rapid gains against the documented risk of significant value erosion in leveraged products.
Twist Bioscience (TWST) trades at $128.06, up 2.68% with a bearish technical signal despite recent AI-driven momentum. The company shows strong revenue growth (2025: $377M, 2026: $432M projected) but continues to report significant losses with negative net margins. Recent news highlights AI partnerships and a $300M stock offering, while analyst consensus remains predominantly bullish with 78.6% buy ratings.
TWST presents a high-risk growth opportunity with accelerating revenue but persistent profitability challenges. The stock's valuation appears stretched at P/S of 18.09, requiring successful execution on AI initiatives and path to EBITDA breakeven. Key risks include cash burn, competitive pressures, and dependence on emerging AI-driven drug discovery markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
